Loading insider details...
Beta
Latest Form 4 (Jun 18, 2026): Exercise/Conversion of 20,000 OABI shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 18, 2026 | OmniAb, Inc. (OABI) | Exercise/Conversion | 20,000 | n/a |
| Nov 3, 2025 | OmniAb, Inc. (OABI) | Exercise/Conversion | 17,769 | n/a |
| Jun 18, 2025 | OmniAb, Inc. (OABI) | Exercise/Conversion | 20,000 | n/a |
| May 12, 2025 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 775 | n/a |
| Nov 1, 2024 | OmniAb, Inc. (OABI) | Exercise/Conversion | 17,769 | n/a |
| Jun 21, 2024 | OmniAb, Inc. (OABI) | Exercise/Conversion | 20,000 | n/a |
| May 20, 2024 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 5,228 | n/a |
| Nov 1, 2023 | OmniAb, Inc. (OABI) | Exercise/Conversion | 17,770 | n/a |
| Jun 27, 2023 | OmniAb, Inc. (OABI) | Grant/Award | 20,000 | n/a |
| Jan 9, 2023 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 4,268 | n/a |